共 6 条
Chasing mutations in the epidermal growth factor in lung cancer
被引:24
作者:

Dowell, JE
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA

Minna, JD
论文数: 0 引用数: 0
h-index: 0
机构: Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
机构:
[1] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA
关键词:
D O I:
10.1056/NEJMe058033
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
引用
收藏
页码:830 / 832
页数:3
相关论文
共 6 条
[1]
Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors
[J].
Blencke, S
;
Ullrich, A
;
Daub, H
.
JOURNAL OF BIOLOGICAL CHEMISTRY,
2003, 278 (17)
:15435-15440

Blencke, S
论文数: 0 引用数: 0
h-index: 0
机构: Axxima Pharmaceut AG, D-81377 Munich, Germany

Ullrich, A
论文数: 0 引用数: 0
h-index: 0
机构: Axxima Pharmaceut AG, D-81377 Munich, Germany

Daub, H
论文数: 0 引用数: 0
h-index: 0
机构: Axxima Pharmaceut AG, D-81377 Munich, Germany
[2]
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
[J].
Kobayashi, S
;
Boggon, TJ
;
Dayaram, T
;
Janne, PA
;
Kocher, O
;
Meyerson, M
;
Johnson, BE
;
Eck, MJ
;
Tenen, DG
;
Halmos, B
.
NEW ENGLAND JOURNAL OF MEDICINE,
2005, 352 (08)
:786-792

Kobayashi, S
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Boggon, TJ
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Dayaram, T
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Janne, PA
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Kocher, O
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Meyerson, M
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Johnson, BE
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Eck, MJ
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Tenen, DG
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA

Halmos, B
论文数: 0 引用数: 0
h-index: 0
机构: Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA
[3]
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
[J].
Lynch, TJ
;
Bell, DW
;
Sordella, R
;
Gurubhagavatula, S
;
Okimoto, RA
;
Brannigan, BW
;
Harris, PL
;
Haserlat, SM
;
Supko, JG
;
Haluska, FG
;
Louis, DN
;
Christiani, DC
;
Settleman, J
;
Haber, DA
.
NEW ENGLAND JOURNAL OF MEDICINE,
2004, 350 (21)
:2129-2139

Lynch, TJ
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Bell, DW
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Sordella, R
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Gurubhagavatula, S
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Okimoto, RA
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Brannigan, BW
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Harris, PL
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Haserlat, SM
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Supko, JG
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Haluska, FG
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Louis, DN
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Christiani, DC
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Settleman, J
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

Haber, DA
论文数: 0 引用数: 0
h-index: 0
机构: Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4]
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
[J].
Paez, JG
;
Jänne, PA
;
Lee, JC
;
Tracy, S
;
Greulich, H
;
Gabriel, S
;
Herman, P
;
Kaye, FJ
;
Lindeman, N
;
Boggon, TJ
;
Naoki, K
;
Sasaki, H
;
Fujii, Y
;
Eck, MJ
;
Sellers, WR
;
Johnson, BE
;
Meyerson, M
.
SCIENCE,
2004, 304 (5676)
:1497-1500

Paez, JG
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Jänne, PA
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Lee, JC
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Tracy, S
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Greulich, H
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Gabriel, S
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Herman, P
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Kaye, FJ
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Lindeman, N
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Boggon, TJ
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Naoki, K
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Sasaki, H
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Fujii, Y
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Eck, MJ
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Sellers, WR
论文数: 0 引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Johnson, BE
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

Meyerson, M
论文数: 0 引用数: 0
h-index: 0
机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5]
Overriding imatinib resistance with a novel ABL kinase inhibitor
[J].
Shah, NP
;
Tran, C
;
Lee, FY
;
Chen, P
;
Norris, D
;
Sawyers, CL
.
SCIENCE,
2004, 305 (5682)
:399-401

Shah, NP
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA

Tran, C
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA

Lee, FY
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA

Chen, P
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA

Norris, D
论文数: 0 引用数: 0
h-index: 0
机构: Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA

Sawyers, CL
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[6]
Cancer: Addiction to oncogenes - The Achilles heal of cancer
[J].
Weinstein, IB
.
SCIENCE,
2002, 297 (5578)
:63-64

Weinstein, IB
论文数: 0 引用数: 0
h-index: 0
机构:
Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA